NEW YORK, May 29 (GenomeWeb News) - Qiagen and CytoPathfinder said last week that they have formed a strategic collaboration to develop tools for high-throughput RNAi screening.
The arrangement would combine Qiagen's siRNA sets with CytoPathfinder's transfection microarray technology, which allows for siRNA screening on a microarray chip.
Registering provides access to this and other free content.
Already have an account?Login Now.
Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.
In Science this week: convergent evolution in bird hemoglobin, and more.
The Wall Street Journal speaks with patients affected by questionable test results from Theranos.
Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.